[Bimanol Polfa in treatment of post-neuroleptic abulic-apathic syndromes in schizophrenic patients].
D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003642:Deanol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010259:Paranoid Disorders / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D012559:Schizophrenia / Q000188:drug therapy*
D000928:Antidepressive Agents; D003642:Deanol
Bimanol Polfa w leczeniu poneuroleptycznego zespołu abuliczno-apatycznego u chorych na schizofrenie.